| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Jusakul, A. Kongpetch, S. Kimawaha, P. Klanrit, P. Loilome, W. Namwat, N. Techasen, A. |
2021 | ||||
| 2. | Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma | Kimawaha, P Thanan, R Jusakul, A Jamnongkan, W Silsirivanit, A Sa-Ngaimwibool, P Titapun, A Khuntikeo, N Sithithaworn, P Worasith, C Janthamala, S Lebrilla, CB Techasen, A |
2022 | ||||
| 3. | Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression. | Sirithawat, P Jusakul, A Kongpetch, S Thanee, M Srichanchara, P Panjaroensak, S Kimawaha, P Janthamala, S Aphivatanasiri, C Techasen, A |
2023 | ||||
| 4. | Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines | Janthamala, S Promraksa, B Thanee, M Duenngai, K Jusakul, A Kongpetch, S Kraiklang, R Thanee, K Pinlaor, P Namwat, N Saya, H Techasen, A |
2024 | ||||
| 5. | Antioxidant and Anticancer Potentials and Metabolic Profiling of Benjakul, A Thai Herbal Preparation | Duenngai, K. Promraksa, B. Janthamala, S. Thanee, M. Sirithawat, P. Wisungre, S. Deechan, S. Meechai, N. Paratang, P. Techasen, A. |
2024 | Count | 4 | 4 | 1 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | รวม | ||||||
| 1. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Jusakul, A. Kongpetch, S. Kimawaha, P. Klanrit, P. Loilome, W. Namwat, N. Techasen, A. |
2021 |
Naunyn-Schmiedeberg's Archives of Pharmacology 10 (394), pp. 2049-2059 |
||||||||
| 2. | Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma | Kimawaha, P. Thanan, R. Jusakul, A. Jamnongkan, W. Silsirivanit, A. Titapun, A. Khuntikeo, N. Sithithaworn, P. Worasith, C. Techasen, A. |
2022 |
Clinica Chimica Acta (536), pp. 142-154 |
||||||||
| 3. | Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines | Janthamala, S. Promraksa, B. Thanee, M. Duenngai, K. Jusakul, A. Kongpetch, S. Kraiklang, R. Thanee, K. Pinlaor, P. Namwat, N. Saya, H. Techasen, A. |
2024 |
BMC Complementary Medicine and Therapies 1 (24), pp. |
||||||||
| 4. | Antioxidant and Anticancer Potentials and Metabolic Profiling of Benjakul, A Thai Herbal Preparation | Duenngai, K. Promraksa, B. Janthamala, S. Thanee, M. Sirithawat, P. Wisungre, S. Deechan, S. Meechai, N. Paratang, P. Techasen, A. |
2024 |
Tropical Journal of Natural Product Research 4 (8), pp. 6877-6883 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. | Janthamala, S Jusakul, A Kongpetch, S Kimawaha, P Klanrit, P Loilome, W Namwat, N Techasen, A |
2021 |
Naunyn-Schmiedeberg's archives of pharmacology 10 (394), pp. 2049-2059 |
|
| 2. | Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma. | Kimawaha, P Thanan, R Jusakul, A Jamnongkan, W Silsirivanit, A Sa-Ngaimwibool, P Titapun, A Khuntikeo, N Sithithaworn, P Worasith, C Janthamala, S Lebrilla, CB Techasen, A |
2022 |
Clinica chimica acta; international journal of clinical chemistry (536), pp. 142-154 |
|
| 3. | Alteration of STK11 Expression Associated With Cholangiocarcinoma Progression. | Sirithawat, P Jusakul, A Kongpetch, S Thanee, M Srichanchara, P Panjaroensak, S Kimawaha, P Janthamala, S Aphivatanasiri, C Techasen, A |
2023 |
In vivo (Athens, Greece) 4 (37), pp. 1638-1648 |
|
| 4. | Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines. | Janthamala, S Promraksa, B Thanee, M Duenngai, K Jusakul, A Kongpetch, S Kraiklang, R Thanee, K Pinlaor, P Namwat, N Saya, H Techasen, A |
2024 |
BMC complementary medicine and therapies 1 (24), pp. 178 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | รวม | ||||||
| 1. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Sutthiwan Janthamala Apinya Jusakul Sarinya Kongpetch Phongsaran Kimawaha Poramate Klanrit Watcharin Loilome Nisana Namwat Anchalee Techasen |
2021 |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 10.0 (394.0), pp. 2049.0-2059.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|